中石化於進博會簽約金額達401億美元 北美進口簽約規模較上屆增長86%
中國石化公布,今日(4日)在第五屆中國國際進口博覽會中國石化主題論壇暨中國石化交易分團簽約儀式上,與來自14個國家、地區的34家合作夥伴採購簽約,涉及原油、化工品、設備及材料等11大類、26種產品,採購簽約金額達401億美元。公司於五屆進博會累計簽約超過2,000億美元。
據悉,與往屆相比,今年歐洲地區進口簽約規模穩定增長,北美地區進口簽約規模比上屆進博會增長86%,加拿大供應商首次出現在中國石化進博會簽約儀式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.